Fujifilm announced an additional investment of $1.2 billion in its large-scale cell culture contract development and manufacturing organization (CDMO) business to further...
Japan’s Fujifilm has agreed to acquire Entegris’ electronic chemicals business for $700 million. The transaction is expected to close by the end of 2023, subject to...
Responding to rising market demand, Japan’s Fujifilm is spending $188 million to establish a manufacturing facility for cell culture media in Research Triangle Park...
Fujifilm is preparing to invest $1.6 billion to ramp up the cell culture manufacturing services of its CDMO subsidiary Fujifilm Diosynth Biotechnologies.
Fujifilm Irvine Scientific, part of Japan’s Fujifilm Holdings, will acquire Shenandoah Biotechnology, a US-based, privately held manufacturer of recombinant proteins...
Fujifilm Diosynth Biotechnologies is investing £400 million to expand its Teesside site in northeast England, where it makes the active ingredient for the Novavax Covid...
Japan’s Fujifilm has pledged an investment package of about $850 million to accelerate the growth of its core bio CDMO subsidiary Fujifilm Diosynth Biotechnologies by...
